Biosimilars
Introduced in the 1980s, biologic medications have since become important tools in modern medicine. However, biologics are expensive, greatly affecting the healthcare budgets of both underdeveloped and developed countries. Fortunately, biosimilars, which are highly similar, reverse-engineered versio...
में बचाया:
| अन्य लेखक: | , |
|---|---|
| स्वरूप: | इलेक्ट्रोनिक पुस्तक अध्याय |
| भाषा: | अंग्रेज़ी |
| प्रकाशित: |
IntechOpen
2022
|
| विषय: | |
| ऑनलाइन पहुंच: | DOAB: download the publication DOAB: description of the publication |
| टैग: |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|
| सारांश: | Introduced in the 1980s, biologic medications have since become important tools in modern medicine. However, biologics are expensive, greatly affecting the healthcare budgets of both underdeveloped and developed countries. Fortunately, biosimilars, which are highly similar, reverse-engineered versions of existing biological medicines and their active ingredients, are now available as more affordable options for patients treated with biologics. This book discusses biosimilars with chapters on clinical trials, regulation, pharmacovigilance, and the interchangeability of biosimilars with biologics. It also addresses future trends in the biosimilars market. |
|---|---|
| भौतिक वर्णन: | 1 electronic resource (106 p.) |
| आईएसबीएन: | intechopen.87638 9781838819439 9781838819354 9781839681677 |
| अभिगमन: | Open Access |